Correction to: Prostate dose escalation may positively impact survival in patients with clinically node-positive prostate cancer definitively treated by radiotherapy: surveillance study of the Japanese Radiation Oncology Study Group (JROSG)
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsProstate Cancer Diagnosis and Treatment · Prostate Cancer Treatment and Research
This is a correction to: Toshiya Maebayashi, Takashi Mizowaki, Hitoshi Ishikawa, Kiyonao Nakamura, Koji Inaba, Hirofumi Asakura, Hiromitsu Iwata, Satoshi Itasaka, Hiroyuki Wada, Masakuni Sakaguchi, Keiichi Jingu, Takeshi Akiba, Natsuo Tomita, Katsumasa Nakamura, Japanese Radiation Oncology Study Group, Prostate dose escalation may positively impact survival in patients with clinically node-positive prostate cancer definitively treated by radiotherapy: surveillance study of the Japanese Radiation Oncology Study Group (JROSG), Journal of Radiation Research, 2025; https://doi.org/10.1093/jrr/rraf005
In the originally published version of the manuscript marked, emendations to Table 6 had been missed. These are now been emended in the article.
Table 6 should read:
instead of: